Azithromycin and bronchiolitis obliterans.
Kanazawa
S
S
Nomura
S
S
Muramatsu
M
M
Yamaguchi
K
K
Fukuhara
S
S
D000893:Anti-Inflammatory Agents / Q000276:immunology / Q000627:therapeutic use*; D017963:Azithromycin / Q000276:immunology / Q000627:therapeutic use*; D001989:Bronchiolitis Obliterans / Q000097:blood / Q000188:drug therapy* / Q000209:etiology*; D001999:Bronchoscopy / Q000009:adverse effects*; D015704:CD4 Antigens / Q000097:blood; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D016040:Lung Transplantation / Q000009:adverse effects; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D009000:Monocytes / Q000187:drug effects / Q000276:immunology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D015704:CD4 Antigens; D015850:Interleukin-6; D017963:Azithromycin